Dear all,
For the mRNA sequencing of the Geuvadis samples, we suggest using the
latest Illumina sample prep kit for HiSeq with 24 indexes:
TruSeq RNA Sample Prep Kit V2 Set A and Set B (RS-122-2001 and RS-122-2002)
As we agreed on the call, you should let me know this week if you don't
agree with using this kit - otherwise we'll go forward with this, and
everyone should to order the kits as necessary to prepare for receiving
the RNAs in the end of October or early November.
Please see the attachment for full information from Illumina for
ordering - as you know, it is absolutely critical that we all follow the
same protocol.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Dear all,
I would like to ask your opinion on potential collaboration in the
future between the Geuvadis RNA sequencing project and the 1000 Genomes
Consortium.
There will be a 1000g project meeting in Montreal in mid-November that I
will attend - me and Manolis belong to the 1000g analysis group. In the
Phase 1 of the project there is now increasing interest to analyze
functional consequences of the discovered variants, also in the
regulatory context.
There's no doubt that the Geuvadis dataset will be hugely valuable in
annotating regulatory variation, which is of interest to many people.
The vast majority of the work will naturally happen within the Geuvadis
framework. However, the really unique property of our dataset is the
combination of genome and transcriptome sequence data, and in my opinion
the expertise that the 1000g people have in analyzing genome sequence
might help us to get the most out of our data, benefiting us all.
So, what would you think of exploring the possibilities for
collaboration? We suggest that I will let relevant people from the 1000g
consortium to know about Geuvadis, and discuss if there would be joint
interests - open the door a little bit, so to say. It goes without
saying all external collaborations would be conditional to full
acceptance by the partners and all due credit to the Geuvadis project.
Please let me know what you think by early October.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
FYI, from Tuuli
-------- Original Message --------
Dear all,
I would like to ask your opinion on potential collaboration in the
future between the Geuvadis RNA sequencing project and the 1000 Genomes
Consortium.
There will be a 1000g project meeting in Montreal in mid-November that I
will attend - me and Manolis belong to the 1000g analysis group. In the
Phase 1 of the project there is now increasing interest to analyze
functional consequences of the discovered variants, also in the
regulatory context.
There's no doubt that the Geuvadis dataset will be hugely valuable in
annotating regulatory variation, which is of interest to many people.
The vast majority of the work will naturally happen within the Geuvadis
framework. However, the really unique property of our dataset is the
combination of genome and transcriptome sequence data, and in my opinion
the expertise that the 1000g people have in analyzing genome sequence
might help us to get the most out of our data, benefiting us all.
So, what would you think of exploring the possibilities for
collaboration? We suggest that I will let relevant people from the 1000g
consortium to know about Geuvadis, and discuss if there would be joint
interests - open the door a little bit, so to say. It goes without
saying all external collaborations would be conditional to full
acceptance by the partners and all due credit to the Geuvadis project.
Please let me know what you think by early October.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch<mailto:tuuli.lappalainen@unige.ch>
FYI, from Tuuli Lappalainen
-------- Original Message --------
Subject:
Geuvadis mRNAseq kit
Date:
Tue, 27 Sep 2011 10:29:00 +0200
From:
Tuuli Lappalainen <Tuuli.Lappalainen(a)unige.ch><mailto:Tuuli.Lappalainen@unige.ch>
To:
geuvadis_rnaseq(a)lists.crg.es<mailto:geuvadis_rnaseq@lists.crg.es> <geuvadis_rnaseq(a)lists.crg.es><mailto:geuvadis_rnaseq@lists.crg.es>
Dear all,
For the mRNA sequencing of the Geuvadis samples, we suggest using the
latest Illumina sample prep kit for HiSeq with 24 indexes:
TruSeq RNA Sample Prep Kit V2 Set A and Set B (RS-122-2001 and RS-122-2002)
As we agreed on the call, you should let me know this week if you don't
agree with using this kit - otherwise we'll go forward with this, and
everyone should to order the kits as necessary to prepare for receiving
the RNAs in the end of October or early November.
Please see the attachment for full information from Illumina for
ordering - as you know, it is absolutely critical that we all follow the
same protocol.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch<mailto:tuuli.lappalainen@unige.ch>
Dear all,
For the mRNA sequencing of the Geuvadis samples, we suggest using the
latest Illumina sample prep kit for HiSeq with 24 indexes:
TruSeq RNA Sample Prep Kit V2 Set A and Set B (RS-122-2001 and RS-122-2002)
As we agreed on the call, you should let me know by the end of September
if you object - otherwise we'll go forward with this, and everyone
should to order the kits as necessary to prepare for receiving the RNAs
in the end of October or early November.
Please see the attachment for full information from Illumina for
ordering - as you know, it is absolutely critical that we all follow the
same protocol.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Dear all, it should be working now
If calling from Spain: 902 125 136
If calling from outside Spain: +34 91 495 18 99
Participant Pin-Code: 764989*
Gabrielle
From: P.A.C._t_Hoen(a)lumc.nl [mailto:P.A.C._t_Hoen@lumc.nl]
Sent: viernes, 16 de septiembre de 2011 17:09
To: Gabrielle Anne Bertier; geuvadis_rnaseq(a)lists.crg.es
Cc: geuvadis_wpl(a)lists.crg.es; G.J.B.van_Ommen(a)lumc.nl; Rut Carbonell Garcia; p.rosenstiel(a)mucosa.de
Subject: RE: SCHEDULE CHANGE GEUVADIS RNA-seq TC 16.09.11 17:00 CET
Dear all
I could not connect to this TC. Others could?
Peter
________________________________
From: Gabrielle Anne Bertier [mailto:gabrielle.bertier@crg.eu]
Sent: Wednesday, September 14, 2011 7:00 PM
To: Gabrielle Anne Bertier; geuvadis_rnaseq(a)lists.crg.es
Cc: geuvadis_wpl(a)lists.crg.es; Hoen, P.A.C. 't (HG); Ommen, G.J.B. van (HG); Rut Carbonell Garcia; Rosenstiel, Philip
Subject: SCHEDULE CHANGE GEUVADIS RNA-seq TC 16.09.11 17:00 CET
Dear all,
To the best convenience of a majority of participants, note that the schedule for the RNAseq TC has been shifted to 17:00 CET.
Details:
Date: Friday 16. Sept;
Time: 17:00-18:00 CET
If calling from Spain: 902 125 136
If calling from outside Spain: +34 91 495 18 99
Participant Pin-Code: 764989*
Kind regards,
Gabrielle
From: geuvadis_wpl-bounces(a)lists.crg.es<mailto:geuvadis_wpl-bounces@lists.crg.es> [mailto:geuvadis_wpl-bounces@lists.crg.es]<mailto:%5bmailto:geuvadis_wpl-bounces@lists.crg.es%5d> On Behalf Of Gabrielle Anne Bertier
Sent: jueves, 01 de septiembre de 2011 17:27
To: geuvadis_rnaseq(a)lists.crg.es<mailto:geuvadis_rnaseq@lists.crg.es>
Cc: Michela Bertero; geuvadis_wpl(a)lists.crg.es<mailto:geuvadis_wpl@lists.crg.es>
Subject: [Geuvadis_wpl] RNA-seq strandedness benchmark
Dear all,
Please find below a message from Philip about RNA study results. We will setup a doodle for a TC to discuss these results.
Please be so kind as to pass this on to any relevant person, and let me know if there's anyone I should add to the Geuvadis RNAseq mailing list.
Kind regards,
Gabrielle
Gabrielle Bertier
Scientific Project Manager
International Collaboration and Sponsorship Office
CRG, Center for Genomic Regulation
Carrer Dr. Aiguader, 88
08003 Barcelona, España
Tel: +34933160374
Mobile: +34639960656
email: gabrielle.bertier(a)crg.es<mailto:gabrielle.bertier@crg.es>
web: www.geuvadis.eu
From: Rosenstiel, Philip [mailto:p.rosenstiel@mucosa.de]<mailto:%5bmailto:p.rosenstiel@mucosa.de%5d>
Sent: jueves, 01 de septiembre de 2011 17:08
To: Gabrielle Anne Bertier; Manolis Dermitzakis
Cc: Xavier Estivill
Subject: WG: RNA-seq strandedness benchmark
Dear RNA friends of gEUVADIS,
Several weeks ago we have committed to perform the benchmarking study for strandedness protocols in the 5 samples with both Illumina GAIIx and SoliD V4 protocols.
Matthias has put a lot of work into this and we would like to discuss the results with you and see how to proceed from here. I think the results are very interesting and are worth following up/finishing.
Best, Philip & Matthias
Prof. Dr. Philip Rosenstiel
Institute of Clinical Molecular Biology
University Kiel
Schittenhelmstr.12
Building 5
24105 Kiel
phone +49/4315971333
mobile +49/1773525080
--
Dr. Ralf Sudbrak
EU Coordinator
MPG Cluster Berlin-Brandenburg
c/o Max Planck Institute for Molecular Genetics
Ihnestr. 63 - 73
D-14195 Berlin
Germany
Fon: +49 (30) 8413 1612
Fax: +49 (30) 8413 1380
sudbrak(a)molgen.mpg.de<mailto:sudbrak@molgen.mpg.de>
Dear all, we are experiencing technical problems. We should be able to connect in 5 minutes. Sorry for the inconvenience.
Gabrielle
-----Original Message-----
From: Manolis Dermitzakis [mailto:Emmanouil.Dermitzakis@unige.ch]
Sent: viernes, 16 de septiembre de 2011 17:02
To: Gabrielle Anne Bertier
Cc: geuvadis_rnaseq(a)lists.crg.es; geuvadis_wpl(a)lists.crg.es; kslopez(a)pcb.ub.cat; Rut Carbonell Garcia
Subject: Re: [Geuvadis_wpl] GEUVADIS RNA-seq TC 16.09.11 17:00 CET
Gabrielle
The pin code is wrong
Please send us the correct one
Thanks,
Manolis
------------------------------------------
Emmanouil (Manolis) Dermitzakis, PhD
Louis-Jeantet Professor
Department of Genetic Medicine and Development
University of Geneva Medical School
1 Rue Michel-Servet (CMU office 9088)
Geneva 1211
Switzerland
Email: emmanouil.dermitzakis(a)unige.ch
Tel: +41 (0) 22 379 5483
Fax: +41 (0) 22 379 5706
website: http://funpopgen.unige.ch/
Admin assistant: Ancilla Stefani,
Tel: +41 22 379 5551
e-mail: Ancilla.Stefani(a)unige.ch
------------------------------------------
Gabrielle Anne Bertier wrote:
>
> FYI, please find below an email from Matthias Barann
>
> Reminder:
>
> RNAseq TC
>
> Date: Today *Friday 16. Sept;*
>
> Time: *17:00-18:00 CET*
>
> If calling from Spain: 902 125 136
>
> If calling from outside Spain: +34 91 495 18 99
>
> Participant Pin-Code: 764989*
>
>
>
> Kind regards,
>
> Gabrielle
>
> ---------- Forwarded message ----------
> From: *Matthias Barann* <mbarann(a)gmail.com <mailto:mbarann@gmail.com>>
> Date: 2011/9/16
> Subject: Re: [Geuvadis_rnaseq] SCHEDULE CHANGE GEUVADIS RNA-seq TC
> 16.09.11 17:00 CET
>
>
> Dear all,
>
> please see attatched an excel sheet with some data regarding the
> stranded protocols for illumina and solid, which we will discuss
> during the telephone conference at 17:00 CET.
>
> best wishes,
> Matthias
>
>
>
> ------------------------------------------------------------------------
>
> _______________________________________________
> Geuvadis_wpl mailing list
> Geuvadis_wpl(a)lists.crg.es
> http://davinci.crg.es/mailman/listinfo/geuvadis_wpl
FYI, please find below an email from Matthias Barann
Reminder:
RNAseq TC
Date: Today Friday 16. Sept;
Time: 17:00-18:00 CET
If calling from Spain: 902 125 136
If calling from outside Spain: +34 91 495 18 99
Participant Pin-Code: 764989*
Kind regards,
Gabrielle
---------- Forwarded message ----------
From: Matthias Barann <mbarann(a)gmail.com<mailto:mbarann@gmail.com>>
Date: 2011/9/16
Subject: Re: [Geuvadis_rnaseq] SCHEDULE CHANGE GEUVADIS RNA-seq TC 16.09.11 17:00 CET
Dear all,
please see attatched an excel sheet with some data regarding the stranded protocols for illumina and solid, which we will discuss during the telephone conference at 17:00 CET.
best wishes,
Matthias
Dear all,
Please find below a message from Philip about RNA study results. We will setup a doodle for a TC to discuss these results.
Please be so kind as to pass this on to any relevant person, and let me know if there's anyone I should add to the Geuvadis RNAseq mailing list.
Kind regards,
Gabrielle
Gabrielle Bertier
Scientific Project Manager
International Collaboration and Sponsorship Office
CRG, Center for Genomic Regulation
Carrer Dr. Aiguader, 88
08003 Barcelona, España
Tel: +34933160374
Mobile: +34639960656
email: gabrielle.bertier(a)crg.es<mailto:gabrielle.bertier@crg.es>
web: www.geuvadis.eu
From: Rosenstiel, Philip [mailto:p.rosenstiel@mucosa.de]<mailto:[mailto:p.rosenstiel@mucosa.de]>
Sent: jueves, 01 de septiembre de 2011 17:08
To: Gabrielle Anne Bertier; Manolis Dermitzakis
Cc: Xavier Estivill
Subject: WG: RNA-seq strandedness benchmark
Dear RNA friends of gEUVADIS,
Several weeks ago we have committed to perform the benchmarking study for strandedness protocols in the 5 samples with both Illumina GAIIx and SoliD V4 protocols.
Matthias has put a lot of work into this and we would like to discuss the results with you and see how to proceed from here. I think the results are very interesting and are worth following up/finishing.
Best, Philip & Matthias
Prof. Dr. Philip Rosenstiel
Institute of Clinical Molecular Biology
University Kiel
Schittenhelmstr.12
Building 5
24105 Kiel
phone +49/4315971333
mobile +49/1773525080
--
Dr. Ralf Sudbrak
EU Coordinator
MPG Cluster Berlin-Brandenburg
c/o Max Planck Institute for Molecular Genetics
Ihnestr. 63 - 73
D-14195 Berlin
Germany
Fon: +49 (30) 8413 1612
Fax: +49 (30) 8413 1380
sudbrak(a)molgen.mpg.de<mailto:sudbrak@molgen.mpg.de>